Sector Update: Healthcare Stocks Mixed Premarket Wednesday

MT Newswires Live

Yesterday

Healthcare stocks were mixed premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.4% higher and the iShares Biotechnology ETF (IBB) down 0.3%.

InnovAge Holding (INNV) shares were up more than 10% after the company reported that it swung to earnings in fiscal Q4 amid stronger-than-expected sales growth.

Seaport Therapeutics (SPTX) stock was nearly 4% higher after the company said its phase 1 driving simulation trial of GlyphAllo met its primary endpoint, with the 375 mg dose showing no next-morning driving impairment versus placebo after multiple-day dosing.

Evommune's (EVMN) phase 2b trial of EVO756 to treat adults with moderate-to-severe atopic dermatitis didn't meet its primary and secondary endpoints in any of the doses studied, the company said. Evommune shares were down more than 8% pre-bell.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/news/2666351825"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2666351825\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2666351825?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-09 21:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2666351825","market":"fut","top_or_hot":-1,"title":"Sector Update: Healthcare Stocks Mixed Premarket Wednesday","media":"MT Newswires Live","content":"<html><body><p> Healthcare stocks were mixed premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.4% higher and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) down 0.3%.</p><p>InnovAge Holding (INNV) shares were up more than 10% after the company reported that it swung to earnings in fiscal Q4 amid stronger-than-expected sales growth.</p><p><a href=\"https://laohu8.com/S/SPTX\">Seaport Therapeutics</a> (SPTX) stock was nearly 4% higher after the company said its phase 1 driving simulation trial of GlyphAllo met its primary endpoint, with the 375 mg dose showing no next-morning driving impairment versus placebo after multiple-day dosing.</p><p><a href=\"https://laohu8.com/S/EVMN\">Evommune</a>'s (EVMN) phase 2b trial of EVO756 to treat adults with moderate-to-severe atopic dermatitis didn't meet its primary and secondary endpoints in any of the doses studied, the company said. Evommune shares were down more than 8% pre-bell.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Healthcare Stocks Mixed Premarket Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Healthcare Stocks Mixed Premarket Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-09 21:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Healthcare stocks were mixed premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.4% higher and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) down 0.3%.</p><p>InnovAge Holding (INNV) shares were up more than 10% after the company reported that it swung to earnings in fiscal Q4 amid stronger-than-expected sales growth.</p><p><a href=\"https://laohu8.com/S/SPTX\">Seaport Therapeutics</a> (SPTX) stock was nearly 4% higher after the company said its phase 1 driving simulation trial of GlyphAllo met its primary endpoint, with the 375 mg dose showing no next-morning driving impairment versus placebo after multiple-day dosing.</p><p><a href=\"https://laohu8.com/S/EVMN\">Evommune</a>'s (EVMN) phase 2b trial of EVO756 to treat adults with moderate-to-severe atopic dermatitis didn't meet its primary and secondary endpoints in any of the doses studied, the company said. Evommune shares were down more than 8% pre-bell.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INNV","symbol_name":"InnovAge Holding Corp.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2666351825","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2666351825","pubTimestamp":1788959818,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Healthcare stocks were mixed premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF  0.4% higher and the iShares Biotechnology ETF  down 0.3%.InnovAge Holding  shares were up more than 10% after the company reported that it swung to earnings in fiscal Q4 amid stronger-than-expected sales growth.Seaport Therapeutics  stock was nearly 4% higher after the company said its phase 1 driving simulation trial of GlyphAllo met its primary endpoint, with the 375 mg dose showing no next-morning driving impairment versus placebo after multiple-day dosing.Evommune's  phase 2b trial of EVO756 to treat adults with moderate-to-severe atopic dermatitis didn't meet its primary and secondary endpoints in any of the doses studied, the company said. Evommune shares were down more than 8% pre-bell.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"INNV":"InnovAge Holding Corp.","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","BK4139":"生物科技","BK4588":"碎股","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","IBB":"生物科技指数ETF-iShares Nasdaq","BK4137":"综合支持服务","HCSG":"Healthcare Svcs Group Inc","LABU":"三倍做多标普生物-Direxion","BK4581":"高盛持仓","BK4585":"ETF&股票定投概念","XBI":"SPDR S&P Biotech ETF","BK4007":"制药","SPTX":"Seaport Therapeutics","BK4196":"保健护理服务","XLV":"健康照护类股ETF-SPDR","EVMN":"Evommune"},"translate_title":"行业更新：周三盘前医疗保健股涨跌互现","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INNV":1,"EVMN":1,"SPTX":1,"XLV":1.5,"IBB":1,"XBI":0.6,"HCSG":1.5,"LABU":0.6},"content_text":"Healthcare stocks were mixed premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.4% higher and the iShares Biotechnology ETF (IBB) down 0.3%.InnovAge Holding (INNV) shares were up more than 10% after the company reported that it swung to earnings in fiscal Q4 amid stronger-than-expected sales growth.Seaport Therapeutics (SPTX) stock was nearly 4% higher after the company said its phase 1 driving simulation trial of GlyphAllo met its primary endpoint, with the 375 mg dose showing no next-morning driving impairment versus placebo after multiple-day dosing.Evommune's (EVMN) phase 2b trial of EVO756 to treat adults with moderate-to-severe atopic dermatitis didn't meet its primary and secondary endpoints in any of the doses studied, the company said. Evommune shares were down more than 8% pre-bell.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}